TickerFactsScreenerDevelopers

ENDONOVO THERAPEUTICS, INC. (ENDV) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2018: $12.9K2019: $93.4K2020: $65.4K2021: $15.0K2022: $10.0K$10.0K
2018Cost of Revenue (USD)2022
Fiscal YearCost of RevenueChange YoY
2022$10.0K-33.3%
2021$15.0K-77.1%
2020$65.4K-30.0%
2019$93.4K+622.2%
2018$12.9K—